Concepedia

Publication | Closed Access

Outcome of patients with advanced gastro-intestinal stromal tumours crossing over to a daily imatinib dose of 800mg after progression on 400mg

DOI

373

Citations

10

References

2005

Year

John Zalcberg, Jaap Verweij, Paolo G. Casali, Axel Le Cesne, Peter Reichardt, Jean‐Yves Blay, M. Schlemmer, M. van Glabbeke, Michelle Brown, Ian Judson
European Journal of Cancer

References

YearCitations

Page 1